PD-Rx Pharmaceuticals, Inc. recalls DULoxetine DR USP
- Published
- 1 Jan 2025
- Units affected
- 70, 90-count bottles
- Agency
- FDA
- Country
- United States
The hazard
CGMP Deviations: the presence of a Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Duloxetine above the interim acceptable intake limit
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
DULoxetine DR USP, 30 mg, 90-count bottle, Rx Only, Packaged by: PD Rx Pharmaceuticals Inc, Oklahoma City, OK 73127, NDC: 43063-877-90
- Brand / company
- PD-Rx Pharmaceuticals, Inc.
- Codes / lots
- Lot # I24E77, A24E49, Exp Date: 04/30/25; J23C50, J23C97, L23B39, L23E98, Exp Date: 01/31/2025
- Distribution
- Distributed within US: FL, MS, WI
- Recall status
- Terminated
Source: U.S. Food and Drug Administration, published 1 Jan 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.